Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects

Clinical trial NCT04207177 · UNKNOWN

Trial details

NCT number: NCT04207177
Sponsor: Oslo University Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Transplant; Complications Immune Suppression

Start date: 2019-10-30
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.